Two Danish diabetes researchers claim that the pharmaceutical industry may be manipulating independent clinical research by controlling access to placebo drugs or devices. In a letter published in the Lancet, Mikkel Christensen and Filip K Knop write that “this could be a major way for the pharmaceutical industry to control scientific information about their drugs.”
